CI U.S. Stock Selection Private Pool

Series I CAD

Not available to retail investors / for approved investors only
 

Fund overview

The pool’s investment objective is to provide long-term capital growth by investing primarily in large-cap U.S. equity and equity-related securities. Any change to the fundamental investment objective must be approved by a majority of votes cast at a meeting of securityholders held for that reason.

Fund details

description of elementelement value
Inception date August 2025
CAD Total net assets ($CAD)
As at 2026-02-27
$1.0 million
NAVPS
As at 2026-03-13
$9.7630
MER (%)
As at 2025-09-30
0.00
Management fee (%) Negotiable
Asset class U.S. Equity
Currency CAD
Minimum investment Negotiable
Distribution frequency Annually
Last distribution $0.0305

Risk rating1

  • Low
  • Low to medium
  • Medium
  • Medium to high
  • High

FUND CODES

I 5034
A 2034
F 4034

Performance2 As at 2026-02-28

*Fund performance is not available for funds with a history of less than one year.

Distribution history3

Payable date Total
2025-12-29 0.0305

Management team

First we'll display the Team Company and then the Team members
Greg Quickmire
Jeremy Rosa
Peter Hofstra

CI U.S. Stock Selection Private Pool

Series I CAD

Not available to retail investors / for approved investors only
 
Portfolio allocations4 As at 2026-02-28
Asset allocation (%)
  • US Equity 86.91
  • International Equity 8.68
  • Canadian Equity 2.60
  • Cash and Equivalents 1.83
  • Other -0.02
Sector allocation (%)
  • Technology 50.07
  • Healthcare 30.27
  • Financial Services 8.44
  • Consumer Services 7.78
  • Cash and Cash Equivalent 1.83
  • Energy 1.63
  • Other -0.02
Geographic allocation(%)
  • United States 86.91
  • Canada 4.43
  • United Kingdom 3.08
  • Taiwan 2.45
  • Netherlands 1.89
  • Cayman Islands 1.26
  • Other -0.02
Top holdings5
Sector (%)
1. NVIDIA Corp Computer Electronics 9.32%
2. Alphabet Inc Cl C Information Technology 7.28%
3. Microsoft Corp Information Technology 7.18%
4. Amazon.com Inc Retail 5.40%
5. Boston Scientific Corp Healthcare Equipment 4.66%
6. Eli Lilly and Co Drugs 4.26%
7. Meta Platforms Inc Cl A Information Technology 4.23%
8. Broadcom Inc Computer Electronics 4.00%
9. Thermo Fisher Scientific Inc Healthcare Equipment 3.54%
10. DexCom Inc Healthcare Equipment 3.37%
11. Apple Inc Computer Electronics 3.21%
12. Mastercard Inc Cl A Diversified Financial Services 3.17%
13. Merck & Co Inc Drugs 3.09%
14. AstraZeneca PLC Drugs 3.08%
15. AbbVie Inc Drugs 3.06%
Over 35,000 financial advisors have chosen CI Global Asset Management as a partner. We believe that Canadians have the best opportunity for investments success by using the services of a professional financial advisor. Learn more at ci.com.